SCHEMBL24306604

SCHEMBL24306604

c1cc2c3c(c1)Oc1cc(-c4ccc5oc6ccccc6c6ccccc6c6ccccc6c5c4)cc4c1B3c1c(cccc1O4)O2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.41
KDM4E B2RXH2 3/20 0.41
ALDH1A1 P00352 3/20 0.41
HPGD P15428 3/20 0.41
NPC1 O15118 3/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
RAB9A P51151 2/20 0.41
CASP3 P42574 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
AHR P35869 2/20 0.38
PLA2G2A P14555 4/20 0.38
PLA2G4A P47712 4/20 0.38
PLA2G10 O15496 1/20 0.38
MAOA P21397 2/20 0.36
GLA P06280 1/20 0.36
CYP3A4 P08684 1/20 0.36
PGAM1 P18669 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24307161 0.93 AHR (0.41) MAPTKDM4EALDH1A1HPGDNPC1
SCHEMBL24307160 0.89 MAPT (0.40) MAPTKDM4EALDH1A1HPGDNPC1
SCHEMBL16890598 0.87 MAPT (0.41) MAPTKDM4EALDH1A1HPGDNPC1
SCHEMBL16889349 0.87 PLA2G2A (0.40) MAPTKDM4EALDH1A1HPGDNPC1
SCHEMBL16889355 0.86 MAPT (0.40) MAPTKDM4EALDH1A1HPGDNPC1
SCHEMBL20908300 0.86 PLA2G2A (0.34) MAPTKDM4EALDH1A1HPGDNPC1
SCHEMBL21793857 0.85 MAPT (0.39) MAPTKDM4EALDH1A1HPGDNPC1
SCHEMBL24307172 0.82 HCRTR1 (0.39) MAPTKDM4EALDH1A1HPGDNPC1
SCHEMBL21793755 0.82 MAPT (0.39) MAPTKDM4EALDH1A1HPGDNPC1
SCHEMBL21983014 0.82 MAPT (0.39) MAPTKDM4EALDH1A1HPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220119418-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2022-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220119418-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES BMI1, OXSR1, EED MAPT 2455/4885KDM4E 2326/4885ALDH1A1 2196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.